LimFlow, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (NCT05313165) | LimFlow, Inc. | 2022-12-22 |
| Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study (NCT04304105) | LimFlow, Inc. | 2020-02-24 |
Track LimFlow, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.